Loading...
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
INTRODUCTION: Interstitial lung disease (ILD) is a frequent extra-articular manifestation of Rheumatoid arthritis (RA), but nowadays there are no randomized controlled clinical trials to support therapeutic guidelines. RA-ILD, especially with UIP pattern, shares some similarities with idiopathic pul...
Saved in:
Published in: | Respir Med Case Rep |
---|---|
Main Authors: | , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Elsevier
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7150508/ https://ncbi.nlm.nih.gov/pubmed/32292694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101051 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|